Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis

Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis






Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis This is an interesting BioTech, Nutra Pharma Corp. (OTCMKTS:NPHC) the company has drug candidates in HIV and Multiple Sclerosis as well as an existing Pain Management product. ReceptoPharm (website) is the Nutra Pharma holding that acts as the drug discovery arm for the Company. Nutra […]






Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis

Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis






Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis Nutra Pharma Corporation (OTCQB:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced a manufacturing alliance today with Omnia Biologics to […]